TDOC earnings call summary

Prepared Highlights

• Consolidated revenue: Q4 $642M, slightly above prior year; full year $2.53B, down 1.5% YoY (CEO).
• Adjusted EBITDA: Q4 $84M (13% margin); full year $281M (11.1% margin) (CEO).
• Net loss per share: Q4 $0.14; full year $1.14 (includes amortization, stock-based comp, goodwill impairment, restructuring, partially offset by tax benefits) (CEO).
• Free cash flow: Full year $167M; cash and equivalents $781M; net debt/EBITDA <0.8x (CEO).
• Integrated Care segment: Q4 revenue $409M (+4.7% YoY), adjusted EBITDA $65M (16% margin); full year revenue $1.58B (+3.3% YoY), adjusted EBITDA $239M (15.1% margin) (CEO).
• BetterHelp segment: Q4 revenue $233M (-6.7% YoY), adjusted EBITDA $18M (7.9% margin); full year revenue $950M (-9% YoY), adjusted EBITDA $42M (4.4% margin) (CEO).
• Chronic Care enrollment: 1.19M at Q4 end, up 2% sequentially; U.S. Integrated Care membership 101.8M (CEO).
• BetterHelp insurance: Live in 20 states + D.C.; >4,500 credentialed providers; >120M covered lives; insurance sessions >1,200/day; annualized revenue run rate >$40M (CEO).
• 2026 guidance: Full year consolidated revenue $2.47B–$2.59B; adjusted EBITDA $266M–$308M; free cash flow $130M–$170M (CEO).
• Q1 2026 guidance: Consolidated revenue $598M–$620M; adjusted EBITDA $50M–$62M (CEO).
• Integrated Care 2026 guidance: Revenue growth 0.4%–3.9% YoY; adjusted EBITDA margin 15.1%–16.1%; U.S. members year-end 97M–100M (CEO).
• BetterHelp 2026 guidance: Revenue -7% to -0.5% YoY; insurance revenue $75M–$90M; adjusted EBITDA margin 3%–4.6% (CEO).
• Stock-based compensation: 2026 projected <$60M, down >$20M vs 2025 (CEO).
• Tariff headwind: 2026 expected $5M–$7M (up from $3M in 2025) (CEO).

Mgmt Quotes

• "Fourth quarter results were generally in line with our previously discussed expectations, including consolidated revenue and adjusted EBITDA both modestly above the midpoint of our guidance ranges." (CEO)
• "We are guiding to a full year adjusted EBITDA margin of 15.1% to 16.1% for Integrated Care, which represents an increase of approximately 45 basis points over 2025 at the midpoint." (CEO)
• "With the traction we expect in our insurance offering, we are focused on scaling it through the year and in turn, moderating the level of advertising and marketing expenditure we expect in 2026." (CEO)
• "We are targeting sequential quarterly revenue improvement for the BetterHelp segment, beginning with the second quarter and continuing through the balance of 2026." (CEO)
• "We entered 2026 on a stronger foundation and renewed underlying momentum driven by new innovations in Integrated Care products and capabilities, strong progress towards scaling BetterHelp Insurance, growth in international markets and continued focus on execution and business fundamentals." (CEO)

Prepared Metrics

Q&A Batch (1-5 of 9)

Q1 — David Roman

• Topic: Business stabilization timeline and path to low-to-mid-single-digit revenue growth
• Key points:
  • Integrated Care faces headwind from subscription-to-visit mix shift; visit revenues have strong underlying growth but not enough to offset subscription revenue decline.
  • Over 50% of Virtual Care revenues now from visits; headwind expected to moderate, with visit growth becoming a driver.
  • Chronic Care sees opportunities in bundled products and recruitables; clinical foundations (data/AI) built over last year aim to drive stronger ROI for clients.
  • BetterHelp growth driven by insurance scaling, entered market mid-2025, expects significant growth in 2026.
• Mgmt stance: Bullish — CEO sees growth potential in integrated care (U.S. + international) and BetterHelp turnaround, acknowledging headwind but pointing to visit growth and insurance scaling.

Q2 — Richard Close

• Topic: Chronic Care cross-sell trends and new product traction
• Key points:
  • Bundling products and crossing populations has had "really good success"; weight programs and bundled products show continued interest.
  • Going forward, focus on population health more broadly; clinical model built over last year positions company to identify care gaps and intervene for high-risk/rising-risk populations.
  • Operating model and value proposition will lean into this for longer-term growth.
• Mgmt stance: Bullish — CEO highlights unique clinical model and bundling success as drivers for future growth, despite day-to-day competition.

Q3 — Daniel Grosslight (Citi)

• Topic: BetterHelp EBITDA margin ramp cadence in 2026
• Key points:
  • Q1 EBITDA implied at ~11% of full year (vs. high teens historically); steeper ramp due to advertising spend variability and investments to scale insurance.
  • Q4 EBITDA expected strongest as ad spend pulled back for holiday season.
  • Levers to high vs. low end of guidance: BetterHelp range wider due to consumer market variability and insurance ramp; Integrated Care range tighter, driven by visit seasonality and Chronic Care enrollment ramp.
• Mgmt stance: Neutral — CFO explains moving parts (ad spend, insurance investments) but provides no specific margin targets; range driven by segment-level variability.

Q4 — Jailendra Singh

• Topic: 2027 RSP discussions and health plan headwind easing
• Key points:
  • Macro environment for health plans (enhanced subsidy expiration, federal changes) continues to sort out; feedback is "mixed."
  • Renewed strategic conversations with health plans about suite of services; examples: Catapult for a large blue plan (Medicare Advantage annual wellness visits) and enhanced 24/7 care offering (avoid unnecessary specialist referrals, close care gaps).
  • Health plan interest in unique solutions is stronger, but no clear trend toward unbundling Virtual Care/Chronic Care from insurance packages.
• Mgmt stance: Neutral — CEO notes mixed macro but sees stronger engagement and strategic interest from health plans; no definitive easing of headwind yet.

Q5 — Sean Dodge

• Topic: BetterHelp margin profile: U.S. vs. international and insurance mix impact
• Key points:
  • International now >24% of BetterHelp consumer revenues; growing nicely with localized models and English-speaking offerings.
  • International has different margin profile (pricing, customer acquisition cost), but bottom-line margins are achieved; mix shift contributes to margin pressure.
  • Insurance scaling also impacts margin profile; over time, insurance expected to have different economic construct (lower CAC, higher LTV, ad spend efficiency).
• Mgmt stance: Bullish — CEO sees international growth and insurance scaling as drivers, with better long-term economics despite near-term margin pressure.

Q&A Batch (6-9 of 9)

Q6 — George Hill

• Topic: AARP relationship economics & BetterHelp marketing spend risk
• Key points:
  • AARP deal is reflected in guidance; includes exclusive mental health access, cash-pay discount (first month), insurance standard cost sharing, virtual webinars/workshops, and 3 months free of better sleep.
  • BetterHelp ad spend correlation with revenue is high; 2026 spend will be down vs 2025, and 2025 was down vs 2024.
  • Mgmt sees opportunity to improve ad efficiency via international growth (different expenditure patterns) and conversion initiatives.
• Mgmt stance: Neutral – built AARP into guidance but uncertain on ultimate demand generation; acknowledges correlation but believes mix of scaling insurance and top-of-funnel activation is correct.

Q7 — Brian Tanquilut

• Topic: BetterHelp insurance-side KPIs and revenue visibility
• Key points:
  • KPIs include: conversion, user acquisition, sessions per user, therapist capacity (number of therapists, session fill rates), gross margin differences, lower customer acquisition costs, and contracted payer rates.
  • 2025 insurance revenue was $13M (largely from Uplift acquisition); 2026 guidance is $75M–$90M, with confidence from current run rate: over 1,200 sessions/day (annualized >$40M) and exit rate ~$100M.
  • Revenue ramp driven by state rollout, utilization, access, awareness, and additional payer contracts.
• Mgmt stance: Bullish – sees removing cost barrier shifting decisions to therapy vs economics; expects lower reacquisition costs and has visibility from weekly data and payer contract additions.

Q8 — Ryan MacDonald

• Topic: CMS access program opportunity for BetterHelp
• Key points:
  • BetterHelp is predominantly focused on commercial business; has launched psychiatry as a lever.
  • CMS access program aligns with value prop, covers mental health and diabetes care; mgmt is evaluating it, noting reimbursement levels and implications.
  • Longer term, mgmt views increased national focus on chronic care as positive for Teladoc programs.
• Mgmt stance: Neutral – evaluating program; no commitment to invest in 2026, but sees alignment and positive macro trend.

Q9 — Jeffrey Garro

• Topic: Integrated Care demand breakdown (health plan vs employer)
• Key points:
  • 2025 ended with solid demand in employer channels and good interest in health plan channels despite challenges (exchange/MA markets).
  • Entering 2026: employer market still has need/interest; health plan channel has more strategic conversations about moving medical costs.
  • Mgmt sees stronger position due to suite of services, investments, and innovations; can complement brick-and-mortar primary care strategies or focus on specific lines of business.
• Mgmt stance: Bullish – positioned well despite macro headwinds; leaning into opportunities to drive cost outcomes and ROI for health plans.